🔎 Trials Near Me

Home › Alzheimer's Disease › NCT07563270

GAPcareAD: A Brief Emergency Department Intervention to Address Post-Fall Care Needs of Persons Living With Dementia and Care Partners

Recruiting

Who can join

Ages 65 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Community-dwelling adult (living at home or assisted living) 65 years-old or older presenting to ED after a fall within the last seven days
* Fall not due to syncope or external force (i.e., struck by car,assault, intoxication)
* Fall not due to serious illness (i.e., stroke, acute myocardial infarction)
* Patients have an identified caregiver
* Patient must have known ADRD or score ≥2 on the AD8 Dementia Interview.
* Anticipated to be discharged to home/assisted living/rehabilitation at the time of consent (i.e. not admitted)
* The patient and/or caregiver have a reliable phone number where they can be reached throughout the intervention

Exclusion Criteria:

* Living in a nursing home
* Patients are admitted to the hospital
* Patients who have advanced cancer and/or are in hospice
* Patients have presence of injuries that prevent mobilization (i.e. pelvic or lower extremity fractures)

About the study

Persons living with dementia (PLWD) are at significantly increased risk for falls, which are the leading cause of emergency department (ED) visits in this population and contribute to serious injuries, functional decline, and caregiver burden. GAPcareAD is an ED-initiated, caregiver-inclusive intervention designed to address fall risk at the point of care. This multi-site trial will compare GAPcareAD (intervention) to usual care for 350 PLWD and caregivers after a fall.

What is being tested

Sponsor: University of Colorado, Denver · Participants: 700 · Started: Oct 13, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07563270

Locations in the U.S.

ColoradoUCH University of Colorado, Aurora
MissouriWashington University, St Louis

Conditions

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.